Important safety considerations include: Separate fiber supplements from medications : Take fiber supplements at least 2 hours apart from oral medications to avoid potential interference with absorption Monitor for obstruction symptoms : Severe abdominal pain, inability to pass gas, or vomiting requires immediate medical evaluation, as FDA labels for GLP-1 medications include rare postmarketing reports of intestinal obstruction (ileus) [1] [2] Coordinate with healthcare providers : Patients with inflammatory bowel disease, diverticulitis history, or other gastrointestinal conditions need individualized fiber recommendations Adjust fluid intake appropriately : Follow medical guidance if you have conditions requiring fluid restriction Patients should contact their healthcare provider if gastrointestinal symptoms persist despite dietary modifications, worsen significantly, or include warning signs such as blood in stool, unintentional weight loss beyond expected therapeutic effects, or severe abdominal pain
While it generally produces less weight loss than newer agents such as tirzepatide, liraglutide remains an effective option for many patients, particularly those who may benefit from a daily medication or for whom other GLP-1 therapies are not appropriate
HIGHLIGHTS: Grab-and-go stick packs
In a statement to CNBC, Humana said it has 15 years of experience administering a temporary Medicare drug coverage program for low-income beneficiaries and will play a similar operational role in Bridge
Standard GLP-1 receptor agonists such as semaglutide work by enhancing insulin secretion, suppressing appetite, and slowing gastric emptying
While some gallstones will sit harmlessly inside the gallbladder, for a minority of patients they will block the release of bile
